Kovitz Investment Group Partners, LLC Biogen Inc. Transaction History

Kovitz Investment Group Partners, LLC

  • $10.5 Billion
  • Q2 2024

A detailed history of Kovitz Investment Group Partners, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Kovitz Investment Group Partners, LLC holds 3,632 shares of BIIB stock, worth $710,528. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,632
Previous 1,827 98.8%
Holding current value
$710,528
Previous $393,000 113.99%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$190.52 - $236.72 $343,888 - $427,279
1,805 Added 98.8%
3,632 $841,000
Q1 2024

May 14, 2024
BUY
$212.02 - $267.71 $387,360 - $489,106
1,827 New
1,827 $393,000
Q1 2022

Apr 22, 2022
SELL
$193.77 - $244.14 $3.07 Million - $3.87 Million
-15,868 Closed
0 $0
Q4 2021

Feb 04, 2022
BUY
$223.92 - $287.77 $61,801 - $79,424
276 Added 1.77%
15,868 $3.89 Million
Q3 2021

Oct 28, 2021
SELL
$282.99 - $369.05 $7,640 - $9,964
-27 Reduced 0.17%
15,592 $4.41 Million
Q2 2021

Aug 04, 2021
SELL
$259.0 - $414.71 $113,442 - $181,642
-438 Reduced 2.73%
15,619 $5.41 Million
Q1 2021

May 06, 2021
BUY
$242.95 - $284.63 $45,917 - $53,795
189 Added 1.19%
16,057 $4.49 Million
Q4 2020

Feb 12, 2021
BUY
$236.26 - $355.63 $3.75 Million - $5.64 Million
15,868 New
15,868 $3.89 Million
Q3 2020

Nov 10, 2020
SELL
$264.77 - $305.71 $54,013 - $62,364
-204 Reduced 1.19%
16,971 $4.81 Million
Q2 2020

Aug 12, 2020
SELL
$258.66 - $342.55 $150,798 - $199,706
-583 Reduced 3.28%
17,175 $4.6 Million
Q1 2020

May 15, 2020
SELL
$268.85 - $341.04 $4.95 Million - $6.28 Million
-18,424 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$220.06 - $304.07 $4.05 Million - $5.6 Million
18,424 New
18,424 $5.47 Million
Q3 2019

Nov 14, 2019
SELL
$217.44 - $243.88 $107,197 - $120,232
-493 Reduced 2.63%
18,239 $4.25 Million
Q2 2019

Aug 14, 2019
BUY
$219.29 - $241.72 $16,666 - $18,370
76 Added 0.41%
18,732 $4.38 Million
Q1 2019

May 15, 2019
SELL
$216.71 - $338.96 $4.01 Million - $6.27 Million
-18,489 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$278.5 - $352.75 $5.15 Million - $6.52 Million
18,489 New
18,489 $5.56 Million

Others Institutions Holding BIIB

# of Institutions
1,050
Shares Held
128M
Call Options Held
1.22M
Put Options Held
1.4M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $28.2B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Kovitz Investment Group Partners, LLC Portfolio

Follow Kovitz Investment Group Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovitz Investment Group Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kovitz Investment Group Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email